Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:4:736-748.
doi: 10.1200/CCI.20.00026.

Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform

Affiliations

Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform

Mireia Crispin-Ortuzar et al. JCO Clin Cancer Inform. 2020 Aug.

Abstract

Purpose: Spatial heterogeneity of tumors is a major challenge in precision oncology. The relationship between molecular and imaging heterogeneity is still poorly understood because it relies on the accurate coregistration of medical images and tissue biopsies. Tumor molds can guide the localization of biopsies, but their creation is time consuming, technologically challenging, and difficult to interface with routine clinical practice. These hurdles have so far hindered the progress in the area of multiscale integration of tumor heterogeneity data.

Methods: We have developed an open-source computational framework to automatically produce patient-specific 3-dimensional-printed molds that can be used in the clinical setting. Our approach achieves accurate coregistration of sampling location between tissue and imaging, and integrates seamlessly with clinical, imaging, and pathology workflows.

Results: We applied our framework to patients with renal cancer undergoing radical nephrectomy. We created personalized molds for 6 patients, obtaining Dice similarity coefficients between imaging and tissue sections ranging from 0.86 to 0.96 for tumor regions and between 0.70 and 0.76 for healthy kidneys. The framework required minimal manual intervention, producing the final mold design in just minutes, while automatically taking into account clinical considerations such as a preference for specific cutting planes.

Conclusion: Our work provides a robust and automated interface between imaging and tissue samples, enabling the development of clinical studies to probe tumor heterogeneity on multiple spatial scales.

PubMed Disclaimer

Conflict of interest statement

Mireia Crispin-Ortuzar

Research Funding: Eli Lilly (Inst)

Marcel Gehrung

Employment: Cyted

Leadership: Cyted

Stock and Other Ownership Interests: Cyted

Consulting or Advisory Role: Cyted, Medtronic

Ferdia A. Gallagher

Honoraria: AstraZeneca (Inst)

Research Funding: GE Healthcare, GlaxoSmithKline, GlaxoSmithKline (I)

Travel, Accommodations, Expenses: CSL Behring (I)

Andrew N. Priest

Speakers' Bureau: GE Healthcare

Travel, Accommodations, Expenses: GE Healthcare

Anne Y. Warren

Consulting or Advisory Role: Roche

Grant D. Stewart

Honoraria: Pfizer, Merck

Consulting or Advisory Role: CMR Surgical

Research Funding: Pfizer, AstraZeneca

Evis Sala

Stock and Other Ownership Interests: Lucida Medical

Honoraria: Siemens Healthineers

Speakers' Bureau: Siemens Healthineers

Travel, Accommodations, Expenses: Siemens Healthineers

Florian Markowetz

Stock and Other Ownership Interests: Tailor Bio

Research Funding: Agilent (Inst)

No other potential conflicts of interest were reported.

Figures

FIG 1.
FIG 1.
A computational framework to create image-based patient-specific tumor molds. (A) The schematic depicts the various steps of the method, bridging from magnetic resonance imaging (MRI) scans to spatially targeted surgical biopsies. The method starts with the delineation of an MRI scan, which is then reoriented, carved out of a 3-dimensional–printed mold, and used for spatially accurate surgical biopsies. The slots of the mold guide the knife for cutting. (B) Flowchart of the different analysis steps performed by the radiology, surgery, pathology, and computational groups to ensure seamless integration between the clinical and research arms. The blue box highlights the computational steps of the pipeline. mpMRI, multiparametric MRI.
FIG 2.
FIG 2.
Optimized, patient-specific tumor molds. Representative T1-weighted magnetic resonance imaging slices and corresponding 3-dimensional renderings of the tumor molds created for the 6 patients included in the study.
FIG 3.
FIG 3.
Validation results. (A) Overlay of the tissue region boundaries (black) and the corresponding magnetic resonance imaging (MRI) segmentations (red) for tumor and kidney regions. Dice similarity coefficients (DSCs) are calculated for tumor and kidney tissues separately. (B) Left: Overlay of a photograph of the section from the first patient and the corresponding MRI maps, including anatomic region segmentations (top) and multiparametric tumor habitats (bottom). Right: Relative distributions of imaging parameters for the 3 tumor habitats. AU, arbitrary units; DCE, dynamic contrast-enhanced; IVIM, intravoxel incoherent motion; RP, renal pelvis; T1w, T1-weighted; T2w, T2-weighted.

References

    1. Longo DL. Tumor heterogeneity and personalized medicine. N Engl J Med. 2012;366:956–957. - PubMed
    1. Sankin A, Hakimi AA, Mikkilineni N, et al. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling. Cancer Med. 2014;3:1485–1492. - PMC - PubMed
    1. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–892. - PMC - PubMed
    1. Turajlic S, Xu H, Litchfield K, et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell. 2018;173:581–594.e12. - PMC - PubMed
    1. Stewart GD, O’Mahony FC, Laird A, et al: Sunitinib treatment exacerbates intratumoral heterogeneity in metastatic renal cancer. Clin Cancer Res 21:4212-4223, 2015. - PubMed

Publication types